Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Advanced Course on Biomarkers for Precision Cancer Medicine 2022: Zurich

25 - 26 Nov 2022

Zurich, Switzerland

ESMO-Advanced-Course-on-Biomarkers-for-Precision-Medicine-2021-1000x1000

Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives
  • To recognize the different modalities of molecular assays needed for contemporary practice of precision oncology
  • To determine the different technologies available for biomarker testing and the context where these technologies are most effective, depending on the nature of the biomarker and the availability of biological samples
  • To comprehend the different modalities of cfDNA testing and their applications in disease monitoring, development of resistance, and minimal residual disease assessment
  • To recognize the applications of multiplex immunophenotyping, spatial transcriptomics and artificial intelligence applied to tissue samples
  • To define the contribution of multidisciplinary teams and tumour boards for therapy decision making

This event has been supported by an unrestricted educational grant from Illumina and MSD.

Hide
Filter by:

There are 10 resources available

AI in Clinical Decision Making

Presenter: S. Försch, DE

Session: Session 1 – Emerging Technologies to Enable Precision Cancer Medicine

Resources:

Slides

100K Genome Project

Presenter: N. Murugaesu, UK

Session: Session 3 - Embedding Precision Oncology Into Clinical Practice: What is Needed & What is Possible

Resources:

Slides

Personalised Immunotherapy

Presenter: K. R. Litchfield, UK

Session: Session 4 - Emerging and Investigational Biomarkers in Immuno-Oncology

Resources:

Slides

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.